These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2946966)

  • 1. Suppressor resident peritoneal macrophages and peritonitis incidence in continuous ambulatory peritoneal dialysis.
    Lamperi S; Carozzi S
    Nephron; 1986; 44(3):219-25. PubMed ID: 2946966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-gamma (IFN-gamma) as in vitro enhancing factor of peritoneal macrophage defective bactericidal activity during continuous ambulatory peritoneal dialysis (CAPD).
    Lamperi S; Carozzi S
    Am J Kidney Dis; 1988 Mar; 11(3):225-30. PubMed ID: 3125740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial peritoneal macrophage function studies in CAPD patients with peritonitis.
    Lin CY; Huang TP
    Adv Perit Dial; 1990; 6():114-9. PubMed ID: 1982786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial changes of interleukin-6 and interleukin-8 levels in drain dialysate of uremic patients with continuous ambulatory peritoneal dialysis during peritonitis.
    Lin CY; Lin CC; Huang TP
    Nephron; 1993; 63(4):404-8. PubMed ID: 8459875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial peritoneal macrophage function studies in new and established continuous ambulatory peritoneal dialysis patients.
    Lin CY; Ku WL; Huang TP
    Am J Nephrol; 1990; 10(5):368-73. PubMed ID: 1964368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic patterns in CAPD patients with peritonitis.
    Lamperi S; Carozzi S
    Clin Nephrol; 1988; 30 Suppl 1():S41-4. PubMed ID: 3052960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory fluids regulate TNF-alpha, but not IL-1 beta, production by human peritoneal macrophages. A study of patients on continuous ambulatory peritoneal dialysis with peritonitis.
    Hart PH; Jones CA; Finlay-Jones JJ
    J Leukoc Biol; 1993 Mar; 53(3):309-19. PubMed ID: 7681094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraperitoneal immunoglobulin (IG) treatment in prophylaxis of bacterial peritonitis in CAPD.
    Lamperi S; Carozzi S; Nasini MG
    Biomater Artif Cells Artif Organs; 1987; 15(1):151-9. PubMed ID: 3329538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CAPD peritonitis induces the production of a novel peptide, daintain/allograft inflammatory factor-1.
    Brauner A; Hertting O; Alkstrand E; Sandberg E; Chromek M; Chen ZW; Ostenson CG
    Perit Dial Int; 2003; 23(1):5-13. PubMed ID: 12691501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological defenses in CAPD.
    Lamperi S; Carozzi S
    Blood Purif; 1989; 7(2-3):126-43. PubMed ID: 2663033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis.
    Zemel D; Koomen GC; Hart AA; ten Berge IJ; Struijk DG; Krediet RT
    J Lab Clin Med; 1993 Dec; 122(6):686-96. PubMed ID: 8245688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneal macrophages from patients on continuous ambulatory peritoneal dialysis show a differential secretion of prostanoids and interleukin-1 beta.
    Fieren MW; van den Bemd GJ; Bonta IL
    Prostaglandins Leukot Essent Fatty Acids; 1992 Sep; 47(1):23-8. PubMed ID: 1438464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the phagocytic cells in children treated with continuous ambulatory peritoneal dialysis.
    Wasik M; Blaim M; Kolewska D; Janota-Krawczyk E; Tomaszewska-Pańczyk M; Sieniawska M
    Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):189-94. PubMed ID: 9597086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritonitis in continuous ambulatory peritoneal dialysis: cytokines in peritoneal fluid and blood.
    Enríquez J; Klínger J; Arturo JA; Delgado M; Tobar C; Mosquera M
    Adv Perit Dial; 2002; 18():177-83. PubMed ID: 12402614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal macrophage beta-2 microglobulin production and bacterial peritonitis in CAPD patients.
    Carozzi S; Nasini G; Schelotto C; Caviglia PM; Canepa M; Zanin T; Cantaluppi A; Salit M
    ASAIO Trans; 1990; 36(3):M369-71. PubMed ID: 2174686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immuno-effector characteristics of peritoneal cells during CAPD treatment: a longitudinal study.
    Betjes MG; Tuk CW; Struijk DG; Krediet RT; Arisz L; Hoefsmit EC; Beelen RH
    Kidney Int; 1993 Mar; 43(3):641-8. PubMed ID: 8455363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of 25-OH-vitamin D3 by peritoneal macrophages from CAPD patients.
    Shany S; Rapoport J; Zuili I; Gavriel A; Lavi N; Chaimovitz C
    Kidney Int; 1991 May; 39(5):1005-11. PubMed ID: 2067195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of CAPD patients with a high incidence of peritonitis to intraperitoneal immunoglobulin therapy.
    Carozzi S; Nasini MG; Kunkl A; Cantarella S; Lamperi S
    ASAIO Trans; 1988; 34(3):635-9. PubMed ID: 3264176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The response of human peritoneal macrophages to stimulation with bacteria isolated from episodes of continuous ambulatory peritoneal dialysis-related peritonitis.
    Mackenzie RK; Coles GA; Williams JD
    J Infect Dis; 1991 Apr; 163(4):837-42. PubMed ID: 1849163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal study of peritoneal defence mechanisms in patients on continuous ambulatory peritoneal dialysis (CAPD).
    McGregor SJ; Brock JH; Briggs JD; Junor BJ
    Perit Dial Int; 1989; 9(2):115-9. PubMed ID: 2488196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.